Paolo Tarantino (@ptarantinomd) 's Twitter Profile
Paolo Tarantino

@ptarantinomd

MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. SoMe Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.

ID: 958742483856486400

calendar_today31-01-2018 16:43:15

13,13K Tweet

26,26K Followers

651 Following

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo
Paolo Tarantino
@ptarantinomd

a year ago

DB06 showed relevant activity with T-DXd for the 1L treatment of HER2-0 (ultralow) MBC. What about in the pretreated setting? In our large RW analysis, after a median of 3 prior lines of treatment, T-DXd showed comparable rwPFS (median 6.3-7.8 months) in HER2-low & HER2-0 MBC.

DB06 showed relevant activity with T-DXd for the 1L treatment of HER2-0 (ultralow) MBC. What about in the pretreated setting? In our large RW analysis, after a median of 3 prior lines of treatment, T-DXd showed comparable rwPFS (median 6.3-7.8 months) in HER2-low & HER2-0 MBC.